Gain Therapeutics, Inc. — Investor Relations & Filings
Gain Therapeutics, Inc. is a clinical-stage biotechnology company that discovers and develops next-generation allosteric small molecule therapies. The company utilizes its proprietary Magellan™ drug discovery platform, which combines artificial intelligence with physics-based computational models to identify novel allosteric binding sites on disease-implicated proteins. This approach aims to modulate protein function to treat diseases that are currently undruggable. The company's lead candidate, GT-02287, is in Phase I clinical trials for the treatment of GBA-Parkinson’s disease. Gain's therapeutic pipeline targets neurodegenerative diseases, lysosomal storage disorders, and other conditions with high unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEF 14A - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-04-28 | English | |
| 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | |
| 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | |
| 8-K - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-03-18 | English | |
| 8-K Filing | 2026-02-03 | English | |
| FORM 8-K | 2025-12-18 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 38172661 | DEF 14A - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-04-28 | English | ||
| 33053358 | 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | ||
| 33053356 | 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | ||
| 32975364 | 8-K - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-03-18 | English | ||
| 31868801 | 8-K Filing | 2026-02-03 | English | ||
|
2025
10 filings
| |||||
| 13280065 | FORM 8-K | 2025-12-18 | English | ||
| 13280066 | FORM S-8 | 2025-12-03 | English | ||
| 13280067 | FORM 8-K | 2025-11-28 | English | ||
| 13280068 | 424B5 | 2025-11-28 | English | ||
| 13280071 | 10-Q | 2025-11-12 | English | ||
| 13280070 | 8-K | 2025-11-12 | English | ||
| 13280069 | S-3/A | 2025-11-07 | English | ||
| 13280072 | FORM 8-K | 2025-10-14 | English | ||
| 13280073 | FORM 8-K | 2025-10-09 | English | ||
| 13280074 | FORM 8-K | 2025-10-06 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Gain Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34440/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34440 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34440 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34440 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34440}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Gain Therapeutics, Inc. (id: 34440)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.